Lanfear Dennis M
SEC insider (Form 3/4/5 filer). CIK 0001420822. President & CEO at Coherus Oncology, Inc. (CHRS). 24 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in REDWOOD CITY, CA.
Companies Lanfear Dennis M has filed insider reports for
- Coherus Oncology, Inc. (CHRS): Director, Officer, President & CEO
Lanfear Dennis M
CIK: 0001420822
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Coherus Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
402.5K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
225K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
402.5K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
125K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
200K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
400K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
450K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
500K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
DispositionDirectStock Option (Right to Buy)
500K shares- - May 29, 2026CHRS
Coherus Oncology, Inc.
AwardDirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 402,500 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 225,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 402,500 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 200,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 450,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Disposition Stock Option (Right to Buy) | 500,000 | - | - | Direct |
| May 29, 2026 | CHRS Coherus Oncology, Inc. | Award Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-10 of 24 transactions